JHX insiders

14 insiders have filed at JHX since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Skelly JonathanPres. James Hardie Na313.5k0.057%nonenone
Singh Jesse GDirector305.6k0.056%nonenone
Erter Aaron MCEO129.8k0.024%nonenone
Hendrickson Gary EDirector128.1k0.023%nonenone
Kilcullen RyanChief Operations Officer66.5k0.012%nonenone
Lada RyanCFO58.4k0.011%nonenone
Peterson Renee JDirector40.8k<0.01%nonenone
Stein NigelDirector39.7k<0.01%nonenone
Majeed FarhajChief Human Resources Officer31.3k<0.01%nonenone
Lisboa Persio VDirector30.3k<0.01%nonenone
Heckes Howard CDirector28.6k<0.01%nonenone
Beastrom TimothyChief Legal Officer12.7k<0.01%nonenone
Rowland Suzanne BDirector12.2k<0.01%nonenone
Pfeifer John CDirector4.3k<0.01%nonenone

No open-market buys or sells have been reported at JHX since 2023Q3. The table shows the filed stakes; it updates when an insider files.

Full register at boothcheck.com/insiders/JHX. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

JHX institutional holders · JHX research report